Real-time enrollment status for this hidradenitis suppurativa clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 12:55 AM UTC
| NCT Number | NCT05889182 |
| Recruiting Status | Recruiting |
| Condition | Hidradenitis Suppurativa |
| Phase | PHASE3 |
| Target Enrollment | 1,328 participants |
| Active Locations | 87 sites in the US |
| Sponsor | AbbVie |
| Last Updated on CT.gov | July 16, 2026 (2 days ago) |
As of July 18, 2026: Clinical trial NCT05889182 is currently recruiting participants. This phase3 study for hidradenitis suppurativa is actively seeking new participants at 87 locations across the United States. The study is sponsored by AbbVie. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05889182 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 87 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05889182 was last updated 2 days ago (July 16, 2026). HelloStudys verifies this status automatically.